Replimune
- Market cap
- 1.24B
- P/E (TTM)i
- -4.19
- P/Bi
- 11.78
- EPSi
- -3.38
- Div yieldi
- 0.00%
- 52W posi
- 79%
Anonymous reader poll. Unscientific, not investment advice.
Shares of Replimune closed at 13.20, down 0.38%. That leaves the company valued at approximately 1.24B, the #3130 most valuable US-listed company we track. The 7 analysts covering the stock are, on balance, at Buy, targeting an average of 19.17 (+45%). The shares sit 79% of the way up their 52-week range of 1.50 to 16.33.
✦ StockVane Quant Insights how this is computed
- Twelve-month momentum in the top 2% of the universe, above its 200-day average.
- Signal has read BUY for 2 months.
- Its last 4 Buy calls have actually lost 14% on average three months out - the strategy's edge here has come from the basket, not from this ticker.
- Recent price momentum is +99.3% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has fallen to 24.1% of float.
- Analyst tilt is Buy.
- Price is above its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 13.25
- Open
- 13.14
- Day range
- 13.01 - 13.60
- Avg price
- 13.26
- Volume
- 1.65M
- Turnover
- 21.85M
- Turnover ratei
- 2.44%
- Volume ratioi
- 0.70
- Amplitudei
- 4.45%
- 52-week rangei
- 1.50 - 16.33
Valuation
- P/Ei
- -3.91
- P/E (TTM)i
- -4.19
- P/Bi
- 11.78
- EPSi
- -3.38
- Book value / shi
- 1.12
- Net profit
- -318.46M
- Net assets
- 105.62M
Share structure
- Market cap
- 1.24B
- Float capi
- 893.02M
- Shares out
- 94.22M
- Float sharesi
- 67.65M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2018-07-20
19.2% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-836.56K net over the window
Short interest
- Shares short
- 22.75M
- % of floati
- 24.15%
- Days to coveri
- 11.14
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Replimune (REPL)?
Replimune last traded at 13.20. The quote on this page refreshes every few seconds while US markets are open.
What is Replimune's market cap?
About 1.24B.
What is the P/E ratio of Replimune?
The trailing twelve-month P/E is -4.19. The Valuation tab shows it against the stock's own five-year range.
Does Replimune pay a dividend?
Replimune does not currently pay a regular dividend.
Is Replimune a buy according to analysts?
The consensus of 7 analysts is a Buy rating, with an average 12-month price target of 19.17, which implies 45.2% upside from the current price. This is not investment advice.
What is Replimune's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Replimune a B (Buy). Twelve-month momentum in the top 2% of the universe, above its 200-day average. Not investment advice.
Quote time 2026-10-08 04:11:04 · For reference only, not investment advice and not tailored to your situation.